Effect Of epigallocatechin-3-gallate on the pharmacokinetics of amlodipine in rats

References

• Adake P, Somashekar HS, Mohammed Rafeeq PK, et al. (2015). Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study. J Adv Pharm Technol Res 6:81–5.
   PubMed Web of Science ®Google Scholar
• Agrawal H, Aggarwal K, Littrell R, et al. (2015). Pharmacological and non-pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev 11:261–9.
   PubMed Web of Science ®Google Scholar
• Amiot MJ, Riva C, Vinet A. (2016). Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review. Obes Rev 17:573–86.
   PubMed Web of Science ®Google Scholar
• Braunlich M, Christensen H, Johannesen S, et al. (2013). In vitro inhibition of cytochrome P450 3A4 by Aronia melanocarpa constituents. Planta Med 79:137–41.
   PubMed Web of Science ®Google Scholar
• Feldman L, Vinker S, Efrati S, et al. (2016). Amlodipine treatment of hypertension associates with a decreased dementia risk. Clin Exp Hypertens 38:545–9.
   PubMed Web of Science ®Google Scholar
• Ferreira A, Rodrigues M, Marques A, et al. (2017). Influence of the dual combination of silymarin and (−)-epigallocatechin gallate, natural dietary flavonoids, on the pharmacokinetics of oxcarbazepine in rats. Food Chem Toxicol 106:446–54.
   PubMed Web of Science ®Google Scholar
• Glesby MJ, Aberg JA, Kendall MA, et al. (2005). Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clin Pharmacol Ther 78:143–53.
   PubMed Web of Science ®Google Scholar
• Graham HN. (1992). Green tea composition, consumption, and polyphenol chemistry. Prev Med 21:334–50.
   PubMed Web of Science ®Google Scholar
• Hsiao HL, Langenickel TH, Greeley M, et al. (2015). Pharmacokinetic drug–drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol. Clin Pharmacol Drug Dev 4:407–17.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao J, Jian W, Wang G. (2018). Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism. Xenobiotica 48:839–44.
   PubMed Web of Science ®Google Scholar
• Khodadoustan S, Nasri Ashrafi I, Vanaja Satheesh K, et al. (2017). Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects. Clin Exp Hypertens 39:520.
   PubMed Web of Science ®Google Scholar
• Kim TE, Ha N, Kim Y, et al. (2017). Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers. Drug Des Devel Ther 11:1409–16.
   PubMed Web of Science ®Google Scholar
• Knop J, Misaka S, Singer K, et al. (2015). Inhibitory effects of green tea and (−)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. PLoS One 10:e0139370.
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Shimazu T, Ohmori K, et al. (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296:1255–65.
   PubMed Web of Science ®Google Scholar
• Lee JE, van Heeswijk R, Alves K, et al. (2011). Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother 55:4569–74.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Xie L, et al. (2016). Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol 54:2886–94.
   PubMed Web of Science ®Google Scholar
• Li T, Liu J, Zheng Y, et al. (2018). Effects of berberine on pharmacokinetics of amlodipine in rats and its potential mechanism. Lat Am J Pharm 37:1–60.
   Web of Science ®Google Scholar
• Mannemala SS, Nagarajan JS. (2015). Development and validation of a HPLC-PDA bioanalytical method for the simultaneous estimation of aliskiren and amlodipine in human plasma. Biomed Chromatogr 29:346–52.
   PubMed Web of Science ®Google Scholar
• Meredith PA, Elliott HL. (1992). Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 22:22–31.
   PubMed Web of Science ®Google Scholar
• Naito T, Kubono N, Ishida T, et al. (2015). CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine. Drug Metab Pharmacokinet 30:419–24.
   PubMed Web of Science ®Google Scholar
• Oh M, Park SE, Ghim JL, et al. (2017). Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers. Drug Des Devel Ther 11:3543–50.
   PubMed Web of Science ®Google Scholar
• Pang J, Zhang Z, Zheng TZ, et al. (2016). Green tea consumption and risk of cardiovascular and ischemic related diseases: a meta-analysis. Int J Cardiol 202:967–74.
   PubMed Web of Science ®Google Scholar
• Park JS, Rehman SU, Kim IS, et al. (2017). Evaluation of herb-drug interactions of Hovenia dulcis fruit extracts. Pharmacogn Mag 13:236–9.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Kim JW, Kim YS, et al. (2014). Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague–Dawley rats. J. Toxicol. Environ. Health Part A 77:1372–83.
   PubMed Web of Science ®Google Scholar
• Son H, Lee D, Lim LA, et al. (2014). Development of a pharmacokinetic interaction model for co-administration of simvastatin and amlodipine. Drug Metab Pharmacokinet 29:120–8.
   PubMed Web of Science ®Google Scholar
• Stopher DA, Beresford AP, Macrae PV, et al. (1988). The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 12:S55–S9.
   PubMed Web of Science ®Google Scholar
• Wang S, Ouyang B, Aa J, et al. (2016). Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model. J Pharm Biomed Anal 126:109–16.
   PubMed Web of Science ®Google Scholar
• Wang ZM, Zhou B, Wang YS, et al. (2011). Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr 93:506–15.
   PubMed Web of Science ®Google Scholar
• Werba JP, Misaka S, Giroli MG, et al. (2015). Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des 21:1213–9.
   PubMed Web of Science ®Google Scholar
• Wu CY, Su TY, Wang MY, et al. (2018). Inhibitory effects of tea catechin epigallocatechin-3-gallate against biofilms formed from Streptococcus mutans and a probiotic lactobacillus strain. Arch Oral Biol 94:69–77.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang X, Lu G, et al. (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human n relevance. Nat Rev Cancer 9:429–39.
   PubMed Web of Science ®Google Scholar
• Yang SH, Cho YA, Choi JS. (2011). Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats. Acta Pharmacol Sin 32:967–72.
   PubMed Web of Science ®Google Scholar
• Yang XX, Hu ZP, Duan W, et al. (2006). Drug–herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des 12:4649–64.
   PubMed Web of Science ®Google Scholar
• Zhang C, Gao Z, Niu L, Chen X. (2018). Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS. Pharm Biol 56:132–7.
   PubMed Web of Science ®Google Scholar
• Zhao W, Baudouin V, Fakhoury M, et al. (2012). Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. Transplantation 93:e29–30.
   PubMed Web of Science ®Google Scholar
• Zheng X, Liu T, Chen X, et al. (2016). Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers. Int J Clin Pharmacol Ther 54:43–51.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang F, Li Q, et al. (2014). Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos 42:245–9.
   PubMed Web of Science ®Google Scholar
• Zuo XC, Zhou YN, Zhang BK, et al. (2013). Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine. Drug Metab Pharmacokinet 28:398–405.
   PubMed Web of Science ®Google Scholar